Avicanna Announces Change in CFO
September 12, 2025 18:00 ET | Source: Avicanna Inc. TORONTO, Sept. 12,…
Update on Information Relating to the General Meeting of September 30, 2025
Update on Information Relating to the General Meeting of September 30, 2025…
Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
— HUTCHMED will host in-person presentation and online webinar on Friday, October…
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer
September 11, 2025 17:01 ET | Source: Achieve Life Sciences SEATTLE and…
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
SINGAPORE, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Armstrong Asia, a leading Singapore-based…
Cloudera Recognized as a Leader in the IDC APAC MarketScape for Unified AI Platforms 2025 Vendor Assessment
This recognition highlights the company’s strength in governance, security, and innovation September…
Correction: Next Technology Holding Inc. Announces Reverse Stock Split
September 11, 2025 18:55 ET | Source: Next Technology Holding Inc. CHEYENNE,…
GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer
Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of…
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to…
Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101
Safety endpoint met, with encouraging signs of efficacy in trial with 23…
